Introduction

33
Engineered microbes can produce a range of valuable bioproducts, providing the basis for a 
43
One option for identifying rare variants from a mutant library is to include a biosensor, such 44 as a metabolite-responsive transcription factor or regulatory RNA, that reports on production of 45 the target small molecule 5, 6 . These biosensors can be highly effective, but they also come with 46 several limitations. Most notably, the biosensor is typically expressed from the same cell that is 47 being engineered or evolved. As a result, mutations can occur in the sensor that disrupt the 48 desired regulation, producing false positive signals that require significant additional screening 6 .
49
An intracellular biosensor also reports on the intracellular small molecule concentration. A 50 product that is rapidly exported may not show a differential signal as the production rate Figure 1A ). We show that competitor strains can be rationally engineered to be 73 inhibited by a target small molecule, that production of the target provides an advantage to the 74 producer, and that spatial structure is required to prevent interactions between producer cells. By
75
combining these elements, we enriched true producer strains from a background of faster-
76
growing non-producers. These high-through selections for small molecule production will enable 77 rapid optimization of engineered microbes.
Results and Discussion
80
Strain design and construction
81
To establish a microbial competition mediated by small molecule production, two different The selection system consists of two strains, one engineered to produce muconate and the 101 other engineered to be inhibited by muconate. Figure 1A) .
111
For the muconate-inhibited strain, we introduced a counterselection module into a The engineered producer strain, JMP15, can convert coumarate to muconate in a series of 131 reactions that conserve little usable energy. Consequently, the strain grows more slowly in 132 minimal media containing glucose when coumarate is also added ( Figure 3A) . The control strain,
133
JMP26, does not show a growth difference.
134
We then grew the producer and control strains of P. putida in co-culture with the muconate-sensitive E. coli. After growth, the P. putida concentration was measured by plating on selective 136 agar. When exogenous muconate was added, both P. putida strains showed large increases in 137 yield ( Figure 3B ). Muconate production provides an advantage when a pure culture of P. putida producers is competed against E. coli ( Figure 3B ). However, when using a mixture of producer and control P.
153 putida, the costs are borne by the individual producers but the benefits, in terms of reduced E.
154
coli competition, are shared. Therefore, when a mixture of control and producer P. putida are 155 competed against E. coli in test tubes, we would expect the control strains to be more fit than the 156 producers. We tested this hypothesis by growing all three strains together, and then separating 157 out the P. putida and counting the fraction of JMP15 and JMP26 colonies. As predicted, the 158 population fraction of JMP15 was unchanged, averaging a 1.0-fold enrichment ( Figure 4A ).
159
Under these conditions, muconate production still increases the fitness of the P. putida, but the 160 control strains share equally in the benefits.
161
Successful selection for efficient producers, therefore, requires a method to limit the benefits 162 of muconate production to the producers. Microfluidic droplets can provide the necessary spatial 
183
This system also streamlines the process of using biosensors in diverse bacteria. and will yield robust strains. The selective pressure can also be tuned in multiple ways, including 200 modifying the sensitivity of the biosensor to its target, changing the initial population ratio of 201 producers and competitors, or engineering the competitor to grow more or less quickly.
202
While the initial selective advantage for a single round of growth in droplets was modest, shorten the time to market.
Media and chemicals
216
All chemicals were from Sigma-Aldrich unless otherwise noted. Strains were routinely 217 propagated in LB or M9 minimal medium containing 2 g/L glucose. Antibiotics were 50 µg/mL 218 kanamycin, 100 µg/mL ampicillin, and 50 µg/mL streptomycin. 
